Calamos Advisors LLC

SEC CIK: 0001316507
Latest filing: Jul 31, 2026

SEC filings (opens in a new tab)

APLS holding history

Apellis Pharmaceuticals, Inc. in every 13F filed by Calamos Advisors LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

APLS overview All 13F holders of APLS Full Q2 2026 holdings

Shares (Q3 2023): 0; Sold out in Q3 2023
Value: $0
% of portfolio: 0.0%
Quarters held: 2; Since Q1 2023

Holdings of APLS by Calamos Advisors LLC, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q3 2023	0	$0	0.0%	−35,133−100.0%	Sold out	Holders
Q2 2023	35,133	$3.20M	<0.1%	−512−1.4%	Reduced	Holders
Q1 2023	35,645	$2.35M	<0.1%	+35,645	New	Holders